February 5, 2022
Pfizer Drops India Vaccine Application After Regulator Seeks Local Trial / Reuters
Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study. The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future.
Any information shared by representatives of “Dr. Morse TV” including (but not limited to) diet, nutritional, herbal, homeopathic, fasting, or any other health modalities, is solely for educational purposes and does not involve or include diagnosing, prognosticating, treatment, or prescribing of remedies for the treatment of diseases and should not be considered a substitute for medically necessary diagnostics.